12:00 AM
 | 
Sep 22, 2008
 |  BioCentury  |  Product Development

Denosumab vs. bisphosphonates

Denosumab vs. bisphosphonates

Denosumab Fosamax alendronate Reclast zoledronic acid
Company Amgen Merck ...

Read the full 145 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >